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Abstract
Background: Buruli ulcer caused by Mycobacterium ulcerans is an infection of the subcutaneous tissue leading to chronic
necrotising skin ulcers. The pathogenesis is associated with the cytocidal and immunosuppressive activities of a macrolide
toxin. Histopathological hallmark of progressing disease is a poor inflammatory response despite of clusters of extracellular
bacilli. While traditionally wide excision of the infected tissue was the standard treatment, provisional WHO guidelines now
recommend an eight week pre-treatment with streptomycin and rifampicin.
Methodology/Principal Findings: We conducted a detailed immunohistochemical analysis of tissue samples from Buruli
patients who received antibiotic treatment. Cellular immune response along with bacterial load and distribution were
monitored. We demonstrate that this treatment leads to the development of highly organized cellular infiltration
surrounding areas of coagulative necrosis. Diffuse infiltrates, granulomas and dense lymphocyte aggregation close to
vessels were observed. Mycobacterial material was primarily located inside mononuclear phagocytes and microcolonies
consisting of extracellular rod-shaped mycobacteria were no longer found. In observational studies some patients showed
no clinical response to antibiotic treatment. Corresponding to that, one of five lesions analysed presented with huge
clusters of rod-shaped bacilli but no signs of infiltration.
Conclusions/Significance: Results signify that eight weeks of antibiotic treatment reverses local immunosuppression and
leads to an active inflammatory process in different compartments of the skin. Structured leukocyte infiltrates with unique
signatures indicative for healing processes developed at the margins of the lesions. It remains to be analysed whether
antibiotic resistance of certain strains of M. ulcerans, lacking patient compliance or poor drug quality are responsible for the
absent clinical responses in some patients. In future, analysis of local immune responses could serve as a suitable surrogate
marker for the efficacy of alternative treatment strategies.
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Introduction
Buruli ulcer (BU) caused by Mycobacterium ulcerans is a chronic
necrotizing skin disease mainly affecting subcutaneous and adipose
tissue [1,2]. The unique pathology of BU is primarily attributed to
a plasmid-encoded macrolide toxin, mycolactone [3,4]. Mycolac-
tone has cytopathic and apoptotic activity and is thought to be
responsible for local immunosuppression by destroying infiltrating
cells [3,5,6]. In animal models, injection of purified mycolactone
causes lesions similar to those produced by wild type M. ulcerans
bacteria [3,7].
BU is considered to be the third most common mycobacterial
infection after tuberculosis and leprosy. Clinical lesions usually
start as painless subcutaneous nodules that may develop into
plaques or oedema. If left untreated, extensive ulcerations with
typical undermined edges of the dermis develop. Spontaneous
healing can occur, often leaving the patient behind with extensive
scarring, retractions and deformities [8–10]. BU has been reported
in more than 30 countries worldwide, but rural communities in
Western and Central Africa are the worst affected [2]. Areas
endemic for BU are associated with stagnant or slow-flowing water
bodies. The mode of transmission is not clear; both contamination
of wounds from environmental reservoirs, such as bio films on
aquatic vegetation [11] and infection through the bite of insect
vectors [12–14] have been discussed.
Until recently, surgery has been the only WHO recommended
treatment for BU [15–17]. Wide excision margins reaching into
the healthy tissue are necessary to prevent recurrences [18] and
often subsequent skin grafting is required. In most endemic areas
access to surgery is very limited for the majority of BU patients.
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often prohibitive. In 2004, WHO published provisional guidelines
recommending treatment with a combination of rifampicin and
streptomycin [19] based on results of a small randomised
controlled clinical trial [20] and observational studies. While no
antibiotic therapy has been formally proven effective in BU [17],
there is evidence that treatment with a combination of rifampicin
and streptomycin reduces recurrence rates and may help to avoid
surgery or at least limit its extent [21]. More than 50% of BU cases
are children below 15 years. Potential long-term side effects of
streptomycin in this population restrict the duration of the
antibiotic treatment to eight weeks. If surgery is combined with
antibiotic therapy, the aim is to use minimal surgery to excise
necrotic tissue when antibiotics have arrested progress of the
disease. For yet unknown reasons, a proportion of BU patients
seem to be refractory for antibiotic treatment.
Histopathological hallmarks of progressing BU are a poor
inflammatory response and growing regions of necrosis of the
dermal and adipose tissue eventually leading to the collapse of the
overlying epidermis (Figure 1; A to D). Clusters of extracellular,
mycolactone-producing acid-fast bacilli are usually located within
these necrotic areas (Figure 1; E and F) [18,22–24]. Granuloma-
tous responses in the dermis and panniculus have been described
in late stages of BU [18,22,25]. Observations both in cell culture
and rodents experimentally infected with mycolactone producing
and mycolactone-negative M. ulcerans strains indicate that in-
filtrating cells are killed due to the cytotoxic and apoptosis
inducing activity of mycolactone [5,26,27]. While M. ulcerans may
be captured by phagocytes during different stages of infection, it
appears to persist only transiently inside these host cells [6,28].
After killing of the phagocytes, extracellular growth leads to the
development of extracellular bacterial foci in areas of coagulating
necrosis [18,27]. The aim of the present study was to analyse
whether the local immunosuppression in Buruli ulcer lesions can
be reversed by the combination treatment with rifampicin and
streptomycin and if intralesional cellular immune responses
complement antibiotic therapy.
Author Summary
Buruli ulcer (BU) is a debilitating disease of the skin
presenting with extensive tissue destruction and suppres-
sion of local host defence mechanisms. Surgical removal of
the affected area has been the standard therapy until in
2004 WHO recommended eight weeks’ treatment with the
anti-mycobacterial drugs rifampicin and streptomycin. We
performed a detailed histological analysis of the local
immune response in biopsies from five children medicated
according to WHO provisional guidelines. One patient still
revealed all histopathological signatures of an active BU
lesion with huge bacterial clusters in areas of fatty tissue
necrosis. Different factors can contribute to treatment
failure, such as poor patient compliance and resistant
bacterial strains. In four patients, different compartments
of the skin presented active immune processes with only
limited residues of bacterial material persisting. We
demonstrated that antibiotic treatment not only directly
controls the infectious agent but is also associated with
fulminant host immune responses. Characterization of the
healing process in BU due to therapy is highly relevant
to increase our knowledge of the impact of treatment
strategies to fight the disease.
Figure 1. Histopathological characteristics associated with untreated Buruli ulcer lesions. Histological sections of specimen from
untreated Buruli ulcer lesions stained with HE (A to D) and ZN (E, F), respectively. Photographs are taken at magnification640 (A, B, E),6100 (C, D) or
61000 (F). (A) Vasculitis associated minor leukocyte infiltration around vessels with intact dermal connective tissue and epidermal hyperplasia. (B)
Extensive areas of necrosis in the deeper dermis and large fat cell ghosts with slight leukocyte infiltrates. (C) Slight cellular infiltration mainly
composed of PMNL. (D) Ongoing necrotic/apoptotic processes surrounding a focus of mycobacterial microcolonies. (E) Typical clusters of
extracellular bacteria between adipose cell ghosts. (F) Sometimes also single bacilli can be spotted inside necrotic regions.
doi:10.1371/journal.pntd.0000002.g001
Reversal of Immunosuppression in Buruli Ulcer
PLoS Neglected Tropical Diseases | www.plosntds.org 2 October 2007 | Volume 1 | Issue 1 | e02Materials and Methods
Clinical specimens
Surgical specimens from five patients aged between six and
11 years with ulcerative lesions were obtained from the Amasa-
man Health Centre in Ghana and the Ayos district hospital in
Cameroon (Table S1). Lesions were not older than three months
and located at the lower leg (four patients) or arm (one patient).
Patients had received the currently recommended standard
treatment comprising surgical excision of lesions after pre-
treatment with a combination of rifampicin and streptomycin
(WHO, 2004). Although no further ulcer enlargement and
reduction of oedema were observed, the responsible clinicians
had decided to treat all five patients surgically to remove necrotic
tissue and facilitate wound healing. After receiving informed
consent from the guardians of the patients, surgical specimens
were used for laboratory reconfirmation of clinical diagnosis and
for detailed immunohistochemical analysis. All five specimens
were positive for at least two of three diagnostic tests applied
(Buruli ulcer-Diagnosis of Mycobacterium ulcerans disease, WHO,
2001), IS2404 PCR, microscopic detection of acid-fast bacilli and
observation of characteristic histopathological changes. After
receiving informed consent the immunologically non responding
patient was tested for HIV positivity. Ethical approval for
analysing patient specimens was obtained from the ethical review
board of the Noguchi Memorial Institute for Medical Research
and the National Ethics Committee of Cameroon.
Immunohistochemistry
Immediately after surgery, specimens with a volume of about
0.5 cm
3 were collected from different areas of the excised lesions
to characterize the gradient of histopathological changes from
necrotic areas to healthy appearing tissue at the excision margins
(Figure S1). Tissue samples were fixed overnight in neutral
buffered 4% paraformaldehyde, transferred to 70% ethanol,
embedded in paraffin according to standard protocols and cut
into 5 mm sections using a microtome. After deparaffinization
sections were rehydrated through graded alcohols, endogenous
peroxidase was blocked with 0.3% H2O2 for 20 min and
unspecific binding prevented by incubating with blocking serum
matching the secondary antibody host (Table 1). Antigen retrieval
treatment was performed according to standard protocol (Dako).
After antigen retrieval antibodies (Table 1) were diluted in PBS
containing 0.1% Tween-20 and slides incubated for 1 h at room
temperature under rocking conditions. Afterwards sections were
incubated for 30 min with a correspondent biotin-conjugated
secondary antibody (Table 1) and for another 30 min with
streptavidin-horseradish peroxidase conjugate (VECTASTAIN
ABC Kit, Vector Laboratories). Staining was performed using
Vector NovaRED and haematoxylin (counterstain). Slides were
subsequently mounted with Eukitt mounting medium.
Staining with Ziehl Neelsen (ZN) and Haematoxylin/Eosin
(HE) was performed on all collected tissue specimen. Staining for
acid-fast bacteria was performed according to WHO standard
protocol (WHO Diagnostic booklet). In brief, sections were
deparaffinized and rehydrated followed by incubation with ZN
carbolfuchsin for 30 min at RT. Subsequently slides were washed
in cool tap water for 5–10 min and individually differentiated with
acid-alcohol. Counterstain was completed with haematoxylin and
slides were mounted with Eukitt mounting medium.
Pictures taken with a Nikon optiphot-2 microscope were saved
using analySIS soft imaging system and processed with Adobe
Photoshop CS.
Results
Lack of a marked inflammatory response and abundant
clusters of extracellular bacilli in one of five antibiotic
treated patients
The excised lesion of one of the five antibiotic treated patients
was almost devoid of cellular infiltrates. Only minor superficial
vasculitis-associated infiltrates of the dermis consisting of lympho-
cytes and macrophages/monocytes were found (Figure 2A).
Extensive connective tissue necrosis and epidermal hyperplasia
was observed (Figure 2A). The adipose regions displayed fat cell
ghosts, extensive calcification and massive necrosis, associated with
nearly complete absence of intact cell structures (Figure 2B;
Table 1. Antibodies used for immunohistochemistry
target antigen stained cell type(s) host (clone) working dilution retrieval method source
CD1a Langerhans cells mouse (O10) prediluted Citrat Beckman Coulter
CD3 T lymphocytes rabbit 1/100 Citrat Dako
CD4 T helper lymphocytes mouse (1F6) 1/100 EDTA Novocastra
CD8 T cytotoxic lymphocytes mouse (4B11) 1/100 EDTA Novocastra
CD14 Phagocytes mouse (7) 1/50 Citrat Novocastra
CD20 B lymphocytes mouse (7D1) 1/100 Citrat Novocastra
CD45RO Activated lymphocytes mouse (UCHL1) 1/100 none Dako
CD56 Natural Killer cells mouse (SPM489) 1/100 Citrat Lab Vision
CD68 Antigen presenting cells mouse (KP1) 1/50 Trypsin Dako
elastase Neutrophilic leucocytes mouse (NP57) 1/50 none Dako
Ki67 Proliferating cells rabbit 1/50 Citrat Dako
S100 Dermal dendrocytes rabbit 1/400 Trypsin Dako
mycobacterial antigens Mycobacteria pAbLep mouse
antiserum
1/1000 Citrat Leprosy Research
Support
biotinylated anti-rabbit IgG Secondary antibody goat 1/200 - Vector
biotinylated anti-mouse IgG secondary antibody horse (rat adsorbed) 1/200 - Vector
doi:10.1371/journal.pntd.0000002.t001
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lesion harboured numerous large clusters of rod-shaped extra-
cellular acid fast bacilli (Figure 2C), margins contained only very
few small bacterial microcolonies (not shown). A polyclonal
antiserum, raised against M. leprae and highly cross-reactive with
other mycobacteria, was used to stain M. ulcerans for confirmation
of ZN staining results. Staining of common mycobacterial antigens
with polyclonal anti-leprae antibody (pAbLep) antiserum and
haematoxylin counterstain revealed an accumulation of myco-
bacteria (Figure 2D; red-brown) close to fat cell ghosts and necrotic
calcified tissue (purple). In-between fat cell ghosts leukocytes
exhibiting signs of defragmentation of nuclei and loss of cytoplasm
were found only sporadically (Figure 2E). Taken together, features of
this lesion resembled that of specimens from untreated patients
(Figure 1) [18]. The patient was tested negative for HIV.
Highly organized inflammatory responses and
intracellular bacterial material in four of five
antibiotic-treated patients
In the other four patients massive cellular infiltration was
observed. Three major types of mixed infiltrates, differing in
cellular composition, architecture and localisation were found in
all four specimens: (i) highly organized epithelioid granulomas of
different size and state of differentiation, primarily located in
deeper dermal tissue (Figure 3A); (ii) less organized diffuse
infiltrates representing the most abundant type, present in all
areas of the dermal connective and adipose tissue (Figure 3B); (iii)
dense lymphocyte clusters in proximity to vessels, occasionally
found in superficial connective tissue (Figure 3C). Cellular
composition and localisation of these structures along with the
distribution of mycobacterial material are also schematically
represented in Figure 3.
Histopathological characteristics of BU were still found in all
four patients. These included psoriasiform and pseudoepithelio-
matous epidermal hyperplasia and depigmentation (Figure 4A)
with exceeding proliferation of keratinocytes (Figure 4B). Addi-
tionally, extensive necrosis of adipose tissue resulted in the
appearance of fat cell ghosts (Figure 4C). Cellular infiltration
was generally more profuse in vicinity to the necrotic centre of
a lesion and declined towards the excision margins. Granulomas
were composed of foamy histiocytes and Langhans’ giant cells
surrounded by lymphocytes and some plasma cells (Figure 4A). No
central caseous necrosis was observed. In deeper adipose tissue
dense infiltration with high proportions of macrophages and new
blood vessel formation were observed (Figure 4C). Occasionally
signs for calcification of deep dermal tissue were present (not
shown). Areas of necrotic connective tissue were encircled by large
accumulations of leukocytes (Figure 4D). Some leukocytes
exhibiting apoptotic features resided inside necrotic regions
(Figure 4D). The periphery of lesions revealed focal superficial
eosinophilia (Figure 4E).
Figure 2. One patient exhibits strong histopathological signs for a progressive Buruli ulcer and large mycobacterial clumps.
Histological sections of the non-responding patient stained with HE (A, B, D) and ZN (C) or polyclonal anti-leprae antibody (pAbLep; E). Magnification
640 (A, B, C, E) and6100 (D). (A) Tissue shows typical signs of advanced Buruli ulcer as deep dermal necrosis, calcification or epidermal hyperplasia.
Leucocytes are found in rare cases around vessels and hardly ever between fat ghosts. (B) Adipose tissue and its surroundings are highly necrotic and
happen to accumulate fat ghosts and calcification. (C) The centre of the necrotic lesion harbours tremendous clumps of rod-shaped mycobacteria. (D)
Staining with pAbLep demonstrates the focal clusters of live bacteria in the necrotic core. (E) If cellular infiltration occurs in small amounts within
some parts of the intradermal adipose tissue cells display apoptotic features.
doi:10.1371/journal.pntd.0000002.g002
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overview of cellular infiltration patterns and distribution of mycobacterial material. Lower part: Three types of cellular infiltration are documented
with HE. (A) Granuloma formation in the connective tissue; magnification 640. (B) Diffuse heterogeneous cellular infiltration of the connective and
adipose tissue; magnification 6100. (C) Follicle-like lymphocyte focus adjacent to vessels; magnification 640.
doi:10.1371/journal.pntd.0000002.g003
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staining (Figure 5A–5D) and immunostaining with pAbLep
antiserum (Figure 5E–5G). Both staining methods were found to
be equally sensitive when compared in serial sections (Figure 5A
and 5B vs. 5E and 5F). In all four patients mycobacterial material
was predominantly found inside macrophages, although some was
still located extra-cellularly; both extra- and intracellular bacilli
had lost their characteristic rod-shape appearance (Figure 5B and
5F). While the cytoplasm of macrophages frequently harboured
numerous phagosomes containing mycobacterial material
(Figure 5C), only a few Langhans’ giant cells with vacuoles
containing ZN and serologically stainable material were located
within granulomas (Figure 5D and 5G, respectively). The highest
burden of mycobacterial material was found in deep dermal
regions (Figure 5A and 5E) with a declining gradient from
ulcerative areas towards the excision margins. Accumulations of
mycobacterial material were primarily observed in areas of mixed
cellular infiltration, but only very rarely in granulomas. Addition-
ally, few residues of microcolonies were present in the upper
dermal connective tissue or close to the epidermal basal layer
(not shown).
Architecture of granulomas
A panel of antibodies specific for leukocyte markers (Table 1)
were used for immunohistochemical characterisation of infiltrates.
Serial sections revealed that the outer layer of granulomas was
mainly composed of CD3
+ T lymphocytes (Figure 6A) with CD4
+
T cells (Figure 6B) always outnumbering CD8
+ T cells (Figure 6C).
These lymphocyte belts were interspersed with S100
+ dermal
dendrocytes (dDCs) (Figure 6D). Occasionally dDCs were present
in the centre of granulomas (not shown). Focal clusters of CD20
+ B
cells appeared at the outer margins of the T lymphocyte layer
(Figure 6E). Cytoplasmic CD68
+ antigen-presenting cells (APCs)
in particular Langhans’ giant cells (Figure 6Finsert) and epithelioid
macrophages formed the centre of granulomas (Figure 6F).
Staining of the membrane protein CD14 confirmed the macro-
phage/monocyte origin of giant cells (Figure 6G, arrow).
Furthermore, large amounts of soluble CD14 were observed
within the belt of T lymphocytes (Figure 6G, arrowhead). A
great proportion of lymphocytes turned out to be activated as
evidenced by their CD45RO
+ phenotype (Figure 6H). Variable
numbers of Ki67
+ (proliferating) cells (Figure 6I) presented
a lymphocyte phenotype (Figure 6Iinsert). Neither elastase
+ poly-
morphonuclear neutrophilic leucocytes (PMNL) nor CD56
+
natural killer (NK) cells could be detected in granuloma
formations.
Cellular composition of diffuse mixed infiltrates
In contrast to granulomas, regions of diffuse cellular infiltration
contained sparsely distributed elastase
+ PMNL (Figure 7A) with
sporadic focal clusters near ulcerative and necrotic areas (not
shown). CD56
+ NK cells showed a similar distribution with
even lower cell counts (not shown). Foci of PMNL and NK cells
with signs of apoptosis were located within necrotic tissue
(Figure 7Ainsert and 7B, respectively). CD3
+ T lymphocyte
(Figure 7C) and foamy histiocytes (not shown) were the most
prominent cell types of mixed infiltrates in the dermal connective
tissue. The CD4
+/CD8
+ cell ratio varied widely between different
regions of a lesion, but usually CD8
+ cells were more abundant
than CD4
+ cells (not shown). Small clusters of CD20
+ B
lymphocytes were scattered within infiltrates (Figure 7D). Counts
of CD14
+ macrophages/monocytes were particularly high in
adipose tissue and around necrotic areas (Figure 7E). Addi-
tionally, vast amounts of sCD14 shed from those cells were
revealed (Figure 7Einsert). Dendritic cells could be detected in
both epidermis and dermis. The frequency of epidermal
CD1a
+ Langerhans cells was strongly elevated (Figure 7F).
S100
+ dDC were distributed throughout diffuse mixed infiltrates
with increasing density towards the margins of necrotic areas
(Figure 7G). Remarkably, dendritic cell appendices reached
into the damaged tissue (Figure 7H). Similar to the findings in
granulomas, a large proportion of lymphocytes stained positive
for the activation marker CD45RO (Figure 7I) and proliferat-
ing Ki67
+ cells were scattered throughout the infiltrate
(Figure 7J).
Figure 4. Histopathology of four patients in response to
rifampicin/streptomycin bi-therapy. Histological sections repre-
sentative for four patients stained with HE (A, C, D, E) and polyclonal
antibody against proliferation marker Ki67 (B). Magnification 640 (A, C,
E) and 6100 (B, E). (A) Psoriatic epidermal hyperplasia typically seen in
Buruli. Diffuse mixed cellular infiltrates in upper and granuloma
formation with Langhans’ giant cells lymphocytes in deeper dermis.
(B) Ki67 staining reveals elevated proliferation levels of keratinocytes in
epidermal basal layer. (C) Cell ghosts of the adipose tissue characteristic
for Buruli infection. Massive mixed cellular infiltrates between fat ghosts
mainly consisting of macrophages/monocytes and formation of new
blood vessels. (D) Necrotic area in deep tissue encircled by extensive
cellular infiltrates. (E) Focal eosinophilia found at margins of the excised
area distant to ulcerative centre.
doi:10.1371/journal.pntd.0000002.g004
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structures
Adjacent to lymphatics or blood-vessels a third type of infiltra-
tion was found, i.e. follicle-like structures with dense aggregations
of lymphocytes (Figure 8A). CD20
+ B lymphocytes were the
dominating cell type (Figure 8B) followed by CD3
+ T lymphocytes
(Figure 8C). Here CD4
+ T cells (Figure 8D) were more frequent
than CD8
+ T cells (Figure 8E). Additionally, few CD68
+ APCs
(Figure 8F) and S100
+ dDCs (Figure 8H) were scattered
throughout the aggregate. Similar to the other two infiltration
types, a large proportion of lymphocytes stained positive for the
activation marker CD45RO (Figure 8G). Single proliferating
Ki67
+ cells were evenly distributed (Figure 8I) and sporadically
hyper-proliferative clusters were encountered (Figure 8I insert).
Discussion
It has been demonstrated recently that treatment with a combi-
nation of rifampicin and streptomycin inhibits the growth of M.
ulcerans inpre-ulcerative BUlesions [19].Furthermore, observational
studies[21]indicatethatatleastinsomeoftheBUpatientsantibiotic
therapy may reduce the extent of or even circumvent the indication
for surgery. Here we present results of a detailed immunohistological
analysis of ulcerative BU lesions from patients treated with
rifampicin/streptomycin prior to surgery. Findings were compared
to those obtained from lesions of patients that have been treated
merely with wide-ranging surgical excision (Figure 1) according to
former WHO treatment guidelines [1,18]. To our knowledge this is
the first detailed immunohistological description of the effect of
antibiotic treatment on BU lesions.
Presentation of the affected tissue of four of the five antibiotic
treated patients was strikingly different from that of untreated
patients, in that immense leukocyte infiltrates and the formation of
new vessels were observed. These findings reconfirm results of
Etuaful et al., who observed an induction of chronic inflammation
and granulomas in pre-ulcerative lesions by antibiotic treatment
[19]. Our detailed analysis regarding composition and architecture
of cellular infiltrates is indicative for the development of highly
organized tertiary lymphoid tissue. Islands of infiltration and
scattered granulomas may also develop in untreated late stage
lesions [18,22,25]. However, infiltration in the patients at hand
was much more substantial, resembling histopathological patterns
observed in conditions such as dermatoborreliosis, where lym-
phoid neogenesis is reported [29]. We found three different types
of infiltration in all four responding patients (Figure 3): granulo-
mas, diffuse mixed infiltrates and dense lymphocyte aggregations
in the vicinity to vessels. We assume that this clear structural
differentiation reflects a range of different functional activities
required for complete clearance of infection and resorption of
necrotic tissue.
In regions of diffuse infiltration, in particular close to areas of
necrosis, outstandingly large amounts of both membrane-bound
and soluble CD14 were found. Consistent with this, it has been
reported that the development of highly organized structures, such
as granulomas, is not required for the resorption of destroyed
tissue [30]. CD14 mediated clearance of necrotic tissue is usually
not associated with an increased expression of inflammatory
cytokines [30], which is in line with the observed lack of major
inflammatory symptoms in the enrolled patients. Necrotic regions
were surrounded by a substantial quantity of dDCs and their
appendices reached into the damaged tissue, indicating enhanced
antigen uptake and presentation. Moreover, elevated numbers of
Langerhans cells were distributed throughout the epidermis, like it
Figure 5. Bacterial load and distribution in four patients. Histological sections representative for four patients stained with ZN (A to D) and
polyclonal anti-leprae antibody (pAbLep; E to G) to demonstrate distribution of mycobacterial material in the excised lesion. Counterstain was
performed with haematoxylin and pictures taken at magnifications of 6100 (A, E), 6200 (G), 6400 (B, F) and 61000 (C, D). (A, E) Serial sections
demonstrate equal detection sensitivity with ZN and pAbLep. Higher amounts of bacterial material near the ulcerative edges with macrophages
being the most prevalent leucocytes. (B, F) Close-up of A and E, respectively. Foci of rounded bacteria located extra- and intracellular between fat
ghosts. (C) Macrophage presenting with mycobacterial material within phagosomal vesicles. (D) Mycobacterial residues appear in rare cases inside
Langhans’ giant cell phagosomal vacuoles. (G) Small granuloma with giant cell formation and traces of mycobacteria inside a phagosome.
doi:10.1371/journal.pntd.0000002.g005
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large proportion of lymphocytes were expressing activation and
proliferation markers. Taken together, these observations reveal
that adaptive immune responses are taking place autonomously.
While in human tuberculosis granulomas develop a central
necrotic core [32], this was not observed in the lesions of the
antibiotic treated BU patients. Here, the centre was mainly formed
of foamy histiocytes and Langhans’ giant cells, like reported for
leprosy [33], and mycobacterial material was only infrequently
detected. In leprosy, cells of the lymphocyte belt are less tightly
packed [34] than in tuberculosis [35], a feature we also observed in
BU lesions. Thus, BU granulomas may function primarily as
a place for antigen presentation and adaptive immune response
rather than for sequestration of the mycobacteria.
In diffuse infiltrates the CD8/CD4 T lymphocyte ratio was
higher than in granulomas. Otherwise, the cellular composition of
both types of infiltration was largely the same. Small islets of
Langhans’ giant cells inside the diffuse infiltrates support the
hypothesis that granulomas represent a more advanced state of the
initially unorganized infiltrations. In contrast, the dense lympho-
cyte aggregations we observed in vicinity to vessels were of
a markedly different cellular composition. Here B lymphocytes
represented the most dominant cell type in contrast to granulomas
or unorganized infiltrates, where small B cell clusters were
distributed more sparsely. B and T lymphocytes were packed in
a notably dense manner, with interspersed dDCs and APCs and
no central core, a composition characteristic also for secondary
lymphoid organs. Similar structures have also been reported by
Ulrichs et al in lung tissue from tuberculosis patients [35]. Many
lymphocytes were in the activated state as demonstrated by
CD45RO staining and a substantial proportion displayed the
proliferation marker Ki67. It has been suggested that these cell
aggregations represent active centres, which orchestrate the local
host defence [35]. It is not clear, which factors play a crucial role
in the development of ectopic lymphoid tissue induced via
antibiotic treatment. Plasmacytoid and myeloid dendritic cells
present in BU lesions prior to antibiotic treatment [36] may play
an important role in this process. Lymphangiogenesis and
participation of lymphoid tissue-inducer cells may represent
hallmarks in the process of lymphoid neogenesis [29]. Although
tertiary lymphoid organs seem to develop in infectious diseases to
sequester pathogens, this process is often accompanied by tissue
damage [29]. Anecdotal reports on the emergence of new
ulcerations in the course of antibiotic treatment of BU, probably
Figure 6. Detailed organization of granulomas. Histological serial sections representative for four patients were stained with antibodies against
different cellular surface or cytoplasmic markers (counterstain haematoxylin). Magnification640 (I),6100 (A, B, C, E, F, G, H, Iinsert),6200 (D) and6400
(Finsert). (A, B, C) Staining with CD3, CD4 and CD8, respectively, reveals a belt of helper as well as cytotoxic T lymphocytes surrounding the APC core.
(D) S100
+ dermal dendrocytes (dDC) spread among T lymphocytes in the outer layer of a granuloma. (E) Focus of CD20
+ B lymphocytes at the border
of a granuloma. (F) CD68
+ APC in the centre of a representative granuloma; insert shows large Langhans’ giant cell. (G) Remarkable large amounts of
membrane bound (arrow) and soluble (arrowhead) CD14 can be observed. (H) Distribution of activated CD45RO
+ lymphocytes. (I) Proliferating Ki67
+
cells indicate the active status of granulomas.
doi:10.1371/journal.pntd.0000002.g006
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this direction. It remains to be analysed whether in some cases
antibiotic treatment may even accelerate the progression of early
plaques and oedemas to ulcerative lesions.
In animal infection models neither wild type nor mycolactone
negative M. ulcerans strains were strong neutrophilic attractants [6],
although other studies reported substantial neutrophilic infiltrates
in early stage infections [28]. Infiltrates in patients treated with
antibiotics contained only very low levels of neutrophilic
leukocytes. In contrast, large numbers of apoptotic cells positive
for the neutrophilic leukocyte marker elastase and the NK cell
marker CD56 were present within necrotic regions. Findings with
an experimental M. ulcerans mouse infection model [27] indicate
that these apoptotic cells represent the residues of an early acute
defence line. Our data show for the first time that cells of this early
defence are destroyed together with the surrounding tissue, if
a substantial infection focus develops. It is most likely that the
generalized cytotoxic activity of mycolactone is the all-dominant
factor.
Lesions of all four responders still harboured mycobacterial
material as revealed by ZN and immunohistochemical staining.
However microcolonies consisting of extracellular [9,22] or
intracellular [37] rod-shaped mycobacterial cells were no longer
found. Stainable mycobacterial material had lost the characteristic
shape and was primarily located inside mononuclear phagocytes,
but was also present in small extracellular foci. These data
indicate a killing or debilitation of the bacteria in the course of
antibiotic treatment. Moreover, antigen uptake and presentation
via macrophages and dendritic cells may be enhanced due to
lower levels of mycolactone. While bacterial residues were
abundant in regions of diffuse infiltration of the deeper dermis
and in adipose tissue, granulomas were largely devoid of it. Only
single Langhans’ giant cells contained vacuoles filled with stainable
residues of the mycobacterial cells. A similar pattern may be found
in active pulmonary tuberculosis [35,38]. Again, these findings
support the theory that granulomas serve as a place for antigen
encounter.
The density of stainable mycobacterial material increased from
the outer margins of lesions towards the ulcerative centre, which
is consistent with the distribution of mycobacterial DNA in
untreated lesions [18,39]. Moreover, our results demonstrate that
after antibiotic treatment the mycobacteria are directly taken up
by phagocytes at the original focus of infection without granuloma
formation. M. ulcerans is able to destroy phagocytes after transient
Figure 7. Composite of mixed cellular infiltrates. Histological sections representative for four patients stained with antibodies against different
cellular markers (counterstain haematoxylin). Magnifications at 640 (A, E, G), 6100 (C, D, F, I, J), 6200 (Ainsert,B ,H )o r61000 (Einsert). (A) Only few
scattered PMNL staining positive for Elastase were found within cellular infiltrates. (Ainsert, B) Neutrophilic and NK cell (CD56
+) foci inside necrotic
areas display signs of advanced apoptosis. (C) Lymphocytes mainly expose a CD3
+ phenotype. (D) Small focal CD20
+ lymphocyte spots are scattered
through infiltrates. (E) Staining against CD14 illustrates large numbers of histiocytes enclosing necrotic tissue shedding massive amounts of sCD14
(insert). (F) Levels of epidermal CD1a
+ Langerhans cells are remarkably elevated compared to healthy skin. (G) Aggregation of S100
+ dDCs near
necrotic spots. (H) Elongated cellular appendices of dDCs reach into the necrotic tissue. (I) Large numbers of lymphocytes are CD45RO
+. (J) Same area
as in (I). Proliferating lymphocytes are highly Ki67
+.
doi:10.1371/journal.pntd.0000002.g007
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think that the stainable intracellular mycobacterial material
represents the remains of phagocytosed dead bacilli or of cells
severely impaired in mycolactone production due to the antibiotic
treatment. In general it is most likely, that a pronounced reduction
of the concentration of mycolactone in the lesion is a prerequisite
for the observed reversal of the local immunosuppression. Due to
the lack of quantitative detection methods for mycolactone, for the
time being this aspect cannot be studied.
The BU lesion of one antibiotic-treated patient displayed
histopathological features similar to active lesions of patients not
receiving antibiotic treatment. Only minor leukocyte infiltration
was found and huge clusters of extracellular mycobacteria were
located beneath the ulcerative centre. Observational studies
indicate that in a certain proportion of patients, rifampicin/
streptomycin treatment has no clinical curative effect. Acquired or
inherited host factors, like deficiencies in the IFN-Y and IL-12
pathways for macrophage activation [40,41], may play a role.
Alternatively, antibiotic resistance of certain lineages of M. ulcerans
could be responsible for this lack of response. Therefore major
efforts should be made to generate M. ulcerans isolates from these
patients for susceptibility testing. Another factor to be considered is
poor patient compliance. Rifampicin is administered once per day
orally and the intake of tablets may not be monitored.
Furthermore, outdated drugs and poorly prepared solutions can
be possible reasons for treatment failure and clearly need to be
taken into consideration.
In summary, we conclude that treatment of BU with rifampicin/
streptomycin is accompanied by a reversion of the local
immunosuppression. The synergistic anti-mycobacterial action of
antibiotics and immune defence mechanisms may be required to
clear the infection efficiently. In view of these results, it may be
suitable to replace streptomycin already after a few weeks by
a bacteriostatic antibiotic. Recently published data of our group
indicate that not everyone exposed to M. ulcerans develops clinical
disease [42]. After exposure a race between front line immune
responses and mycobacterial multiplication seems to decide whether
a chronic infection focus is established or not. Once a bacterial
cluster is large enough to develop a cytocidal cloud of mycolactone
around itself, necrotic areas with only minor infiltration develop
[18,22–25,43], which is in stark contrast to the vigorous immune
responses we describe in the present study. We infer that a complex
and highly organized cellular immune response is crucial for
elimination of a chronic M. ulcerans infection. Efficient triggering of
local immune responses may thus represent a suitable auxiliary
marker for the efficacy of alternative treatment strategies.
Supporting Information
Figure S1 Sampling of tissue for immunohistochemistry
Found at: doi:10.1371/journal.pntd.0000002.s001 (5.14 MB TIF)
Table S1 Main data of enrolled patients
Found at: doi:10.1371/journal.pntd.0000002.s002 (0.03 MB
DOC)
Figure 8. Follicle-like lymphocyte foci reveal organized cellular formation. Serial sections of a representative lymphocyte focus stained with
HE (A; magnification 640) or with antibodies against different cellular markers and haematoxylin as counterstain (B to I; magnification 6100). (A)
Large aggregate of lymphocytes in the upper dermal layer between two venules. Square marks area of magnification chosen for pictures B to I. (B)
CD20+ B lymphocytes build the most abundant cell subset. (C, D, E) Staining against CD3, CD4 and CD8, respectively, exposes also high loads of T
lymphocytes with T helper clearly being more prevalent than cytotoxic T cells. (F) APCs (CD68+) are scattered throughout the entire structure. (G)
Activated lymphocytes appear positive for CD45RO staining. (H) S100+ dermal dendrocytes (dDC) lie in between lymphocytes. (I) Ki67 staining
demonstrates certain proliferation of cells and occasional appearance of discrete spots of hyperproliferation (insert).
doi:10.1371/journal.pntd.0000002.g008
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